What is disulfiram 500mg used for?

In the pharmaceutical industry, Disulfiram 500 mg is a specialized alcohol-deterrent agent. As a pharmacist, I characterize Disulfiram not as a “cure” for alcoholism, but as a potent pharmacological “deterrent” that creates an immediate, highly unpleasant physical sensitivity to alcohol, supporting behavioral modification.

Primary Clinical Use

  • Chronic Alcoholism Management: It is indicated as an aid in the management of selected patients who want to remain in a state of enforced sobriety. The 500 mg dose is typically the initial loading dose (taken for 1–2 weeks) before the patient is titrated down to a maintenance dose of 250 mg.

Mechanism of Action: The “Acetaldehyde Trap”

Disulfiram interferes with the normal metabolic pathway of alcohol. Usually, alcohol is converted to acetaldehyde, which is then quickly broken down into harmless acetic acid by the enzyme aldehyde dehydrogenase (ALDH).

Enzyme Inhibition: Disulfiram irreversibly inhibits the ALDH enzyme.

Acetaldehyde Buildup: If the patient consumes even a small amount of alcohol while on Disulfiram, acetaldehyde levels in the blood rise to 5–10 times higher than normal.

The Disulfiram-Alcohol Reaction: This buildup triggers an immediate and severe physical reaction, including:

    • Flushing and intense throbbing headache.

    • Nausea and copious vomiting.

    • Tachycardia (rapid heartbeat) and hypotension.

    • Dyspnea (shortness of breath).

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Disulfiram 500 mg is a high-precision product with specific requirements:

  • API Stability: As a WHO-GMP manufacturer, we ensure the Disulfiram API meets strict BP/USP/IP monographs. The molecule is relatively stable, but we monitor for potential degradation into diethylamine and carbon disulfide.

  • Formulation Types: While standard tablets are common, we also manufacture dispersible tablets to ensure ease of administration in clinical settings where supervised dosing is required.

  • Packaging for Export: Because Disulfiram is sensitive to moisture, we utilize Alu-Alu blister packaging to ensure a 36-month shelf life for export to Zone IVb climates (Africa, SE Asia, and Latin America).

  • B2B & Institutional Supply: This is a core product for rehabilitation centers and government health departments. Our Mumbai facility provides the CTD/eCTD Dossiers and stability data required for international registration.

What is diethylcarbamazine citrate 50mg used for?

In the pharmaceutical industry, Diethylcarbamazine Citrate (DEC) 50 mg is a highly specific anthelmintic (anti-parasitic) agent. As a pharmacist, I classify DEC as a cornerstone medication for the elimination of microfilariae, making it a critical tool in global public health initiatives aimed at eradicating lymphatic filariasis.

Primary Clinical Uses

  • Lymphatic Filariasis (Elephantiasis): The primary treatment for infections caused by Wuchereria bancrofti, Brugia malayi, and Brugia timori. It is used both for individual clinical cases and in Mass Drug Administration (MDA) programs.

  • Tropical Pulmonary Eosinophilia (TPE): Indicated for this specific respiratory manifestation of filarial infection to reduce eosinophil counts and alleviate asthmatic symptoms.

  • Loiasis: Treatment of “African eye worm” caused by Loa loa.

  • Toxocariasis (Visceral Larva Migrans): Occasionally used as an alternative treatment for infections caused by Toxocara canis or Toxocara cati.

Mechanism of Action

The exact mechanism of DEC is unique compared to other anti-parasitics like Ivermectin. It works through a dual pathway:

Sensitization of Microfilariae: DEC alters the microfilarial surface membranes, making them “visible” to the host’s immune system. This allows the host’s own phagocytes to identify, attack, and clear the parasites from the bloodstream.

Organelle Interference: It interferes with the parasite’s intracellular metabolism, specifically affecting the microtubular structure and arachidonic acid metabolism, which immobilizes the microfilariae.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, DEC 50 mg is an essential medication with specific technical requirements:

  • Dose Uniformity for Titration: Since 50 mg is often a starting or pediatric dose (with 100 mg being the adult standard), as a WHO-GMP manufacturer, we ensure precise blending and micronization of the API to maintain assay consistency across all batches.

  • Stability for Export: DEC is relatively stable, but we prioritize PVC/PVDC or Alu-Alu blister packaging to protect against the high humidity of Zone IVb regions (tropical Africa and Southeast Asia) where the disease is endemic.

  • WHO & NGO Tenders: This product is a staple for international health organizations and government supply chains. Our Mumbai facility provides the necessary CTD/eCTD Dossiers and stability data to participate in these large-scale B2B and public health tenders.

  • Pharmacovigilance (Mazzotti Reaction): We ensure our Product Information Leaflets (PIL) provide clear guidance on managing the “Mazzotti-type” reaction—an immune response to dying microfilariae—which is a critical safety consideration for this drug.

What is diclofenac potassium and Paracetamol tablets used for?

In the pharmaceutical industry, the combination of Diclofenac Potassium (50 mg) and Paracetamol (325 mg or 500 mg) is a powerhouse Fixed-Dose Combination (FDC). As a pharmacist, you recognize this as a “dual-pathway” analgesic strategy that provides superior relief compared to using either agent alone, making it a staple for acute and chronic pain management.

Primary Clinical Uses

  • Musculoskeletal Pain: Highly effective for backaches, sprains, strains, and sports-related injuries where both pain and localized swelling are present.

  • Arthritic Conditions: Used to manage acute flares of Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis by reducing joint stiffness and inflammation.

  • Post-Operative & Post-Traumatic Pain: Frequently prescribed after surgeries or dental procedures (like tooth extractions) to manage inflammation-driven pain.

  • Acute Dental & ENT Pain: Targeted relief for severe toothaches, earaches, and throat pain.

  • Gynae-related Pain: Effective for primary dysmenorrhea (painful menstrual cramps) due to its potent anti-prostaglandin activity.

Mechanism of Action: The Synergistic Advantage

This combination addresses pain from two different physiological directions:

Diclofenac Potassium (Peripheral Action): It is a potent NSAID that inhibits COX-1 and COX-2 enzymes. By blocking the synthesis of prostaglandins at the site of injury, it directly reduces inflammation, swelling, and localized pain. The “Potassium” salt is chosen for its rapid dissolution, ensuring a faster onset of action than the sodium version.

Paracetamol (Central Action): It primarily acts on the Central Nervous System (CNS) to increase the overall pain threshold. It also serves as an antipyretic (fever reducer). While it has minimal anti-inflammatory effect, it complements Diclofenac by providing a second layer of pain relief.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing standpoint, this FDC is a high-volume product requiring precise pharmaceutical engineering:

  • Bilayer Tablet Formulation: As a WHO-GMP manufacturer, we often utilize bilayer technology to separate the two active ingredients. This can be used to create a “Fast-Release” Paracetamol layer and a “Sustained-Release” Diclofenac layer, ensuring immediate relief with prolonged anti-inflammatory coverage.

  • Excipient Synergy: We focus on the selection of super-disintegrants to ensure that the Diclofenac Potassium reaches peak plasma concentration ($T_{max}$) as quickly as possible, justifying the “fast-acting” label.

  • Packaging for Stability: Due to the hygroscopic nature of Paracetamol and the light sensitivity of Diclofenac, we utilize Alu-Alu blister packaging or high-grade PVC/PVDC. This ensures a 36-month shelf life for export to hot and humid Zone IVb climates.

  • Dossier Support: Our Mumbai facility provides comprehensive CTD/eCTD Dossiers and comparative dissolution studies (IP/BP/USP) to help international B2B partners register the product in African, Southeast Asian, and Middle Eastern markets.

 

What are Diclofenac Potassium 50 mg tablets used for?

In the pharmaceutical industry, Diclofenac Potassium 50 mg is a potent, fast-acting non-steroidal anti-inflammatory drug (NSAID). As a pharmacist, I distinguish this from the Sodium salt primarily by its pharmacokinetics: the Potassium salt is more water-soluble, allowing for rapid absorption and a faster onset of analgesic action, making it the preferred choice for acute pain.

Primary Clinical Uses

  • Acute Pain Relief: Specifically indicated for the rapid treatment of acute painful conditions such as migraine attacks, toothaches, and post-operative pain.

  • Primary Dysmenorrhea: Widely used to manage severe menstrual cramps due to its ability to quickly inhibit prostaglandin synthesis in the uterus.

  • Musculoskeletal Injuries: Effective for acute sprains, strains, and sports injuries where rapid reduction of inflammation and pain is required.

  • Inflammatory Conditions: Management of flare-ups in Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis.

Mechanism of Action

Diclofenac Potassium works by inhibiting the enzymes Cyclooxygenase-1 (COX-1) and Cyclooxygenase-2 (COX-2). This inhibition halts the conversion of arachidonic acid into prostaglandins, which are the primary mediators of pain, fever, and inflammation.

Because the potassium salt dissolves more quickly in the stomach’s neutral-to-acidic environment than the sodium version, it reaches peak plasma concentration ($T_{max}$) in approximately 20–60 minutes, compared to 2 hours for the sodium salt.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Diclofenac Potassium 50 mg is a high-demand “fast-relief” product:

  • Non-Enteric Coating: Unlike the sodium version (which is often enteric-coated for slow release), the potassium version is usually film-coated. This ensures the tablet disintegrates immediately in the stomach for rapid absorption.

  • Hygroscopic Protection: Diclofenac Potassium is more sensitive to moisture than the sodium salt. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging to ensure the stability of the API and maintain a 36-month shelf life in Zone IVb climates.

  • API Purity: We adhere to strict BP/USP/IP standards, monitoring for impurities like “Indolinone” to ensure the highest safety profile for export.

  • B2B & Tender Supply: This is a staple for pharmacy chains and emergency medical supplies. Our Mumbai-based hub provides full CTD/eCTD Dossiers to support international partners in rapid registration.

 

 

What does 5mg of Diazepam do?

In the pharmaceutical industry, Diazepam 5 mg is considered a mid-range, versatile dose of a classic long-acting benzodiazepine. As a pharmacist, you recognize it as a “gold standard” for its rapid onset and its multi-functional profile as an anxiolytic, anticonvulsant, and skeletal muscle relaxant.

Primary Clinical Actions

At a 5 mg dose, Diazepam produces several distinct physiological effects:

  • Anxiolytic (Anti-Anxiety): It reduces acute anxiety, tension, and agitation by “quieting” the central nervous system.

  • Skeletal Muscle Relaxation: It is highly effective at relieving muscle spasms caused by local pathology (like inflammation or trauma) or upper motor neuron disorders (like cerebral palsy).

  • Anticonvulsant: It increases the seizure threshold, making it a vital adjunct for managing certain types of epilepsy.

  • Sedation & Pre-medication: It provides mild to moderate sedation, often used to relieve anxiety before minor surgical or dental procedures.

  • Alcohol Withdrawal: It helps mitigate the symptoms of acute alcohol withdrawal, such as tremors and agitation.

Mechanism of Action

Diazepam acts as a positive allosteric modulator of the  receptor. It binds to a specific site on the receptor that is distinct from the binding site of the neurotransmitter GABA.

When Diazepam binds, it increases the frequency with which the associated chloride channel opens in response to GABA. This allows more chloride ions to enter the neuron, causing hyperpolarization. This makes the neuron less excitable and inhibits the transmission of “stress” or “spasm” signals throughout the brain and spinal cord.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Diazepam 5 mg is a high-volume staple:

  • Pharmacokinetic Profile: Diazepam has a very long half-life (up to 48 hours) and active metabolites (like desmethyldiazepam) that extend its action. As a manufacturer, we must ensure our Product Information Leaflets (PIL) clearly state the risk of “accumulation” with repeated dosing.

  • Stability & Sensitivity: Diazepam is sensitive to light. As a WHO-GMP manufacturer, we utilize opaque PVC/PVDC or Alu-Alu blister packaging to prevent degradation and maintain a 36-month shelf life.

  • Controlled Substance Compliance: As a Schedule IV (or equivalent) controlled substance, its export requires strict licensing. Our Mumbai facility is equipped to handle the complex regulatory documentation needed for legal B2B international trade.

  • Digital Promotion: For your e-commerce and marketplace platforms, Diazepam is a “high-trust” product. Highlighting WHO-GMP certification and Bioequivalence (BE) studies against the innovator (Valium) is key to attracting international traders.

 

What is Dexamethasone 0.5 mg used for?

In the pharmaceutical industry, Dexamethasone 0.5 mg is a highly potent, long-acting synthetic glucocorticoid. As a pharmacist, I view this low-strength tablet as a precision tool for managing chronic inflammatory states or as a diagnostic aid, given that Dexamethasone is approximately 25 to 30 times more potent than hydrocortisone.

Primary Clinical Uses

  • Endocrine Disorders: Used as a replacement therapy for primary or secondary adrenocortical insufficiency (though hydrocortisone is more common, dexamethasone is used for its long half-life).

  • Dexamethasone Suppression Test (DST): The 0.5 mg dose is the standard strength used by endocrinologists to diagnose Cushing’s Syndrome. It helps determine if the body’s ACTH production can be suppressed by exogenous steroids.

  • Allergic Conditions: Management of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment, such as bronchial asthma or serum sickness.

  • Rheumatic & Collagen Disorders: Used during an acute exacerbation of rheumatoid arthritis, systemic lupus erythematosus (SLE), or acute rheumatic carditis.

  • Dermatologic Diseases: Treatment of severe erythema multiforme (Stevens-Johnson syndrome) or exfoliative dermatitis.

Mechanism of Action

Dexamethasone works by diffusing across cell membranes and binding with high affinity to specific cytoplasmic glucocorticoid receptors.

Anti-inflammatory: It inhibits the synthesis of inflammatory mediators (prostaglandins and leukotrienes) by inducing lipocortins, which inhibit the enzyme Phospholipase $A_2$.

Immunosuppressive: It reduces the activity and volume of the lymphatic system, suppresses the production of antibodies, and inhibits the release of cytokines (like IL-1 and IL-2).

Metabolic: Unlike many other steroids, Dexamethasone has almost zero mineralocorticoid activity, meaning it does not cause significant sodium retention or edema, making it ideal for treating cerebral edema.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Dexamethasone 0.5 mg is a high-precision product:

  • Low-Dose Uniformity: Because the API is extremely potent at 0.5 mg, as a WHO-GMP manufacturer, we utilize validated geometric dilution and micronization to ensure every tablet has an identical assay.

  • API Stability: Dexamethasone is sensitive to light. We utilize opaque PVC/PVDC or Alu-Alu blister packaging to ensure a stable 36-month shelf life, especially for export to Zone IVb regions (Africa, SE Asia).

  • B2B & Hospital Supply: This is a staple for oncology and endocrinology departments. Our Mumbai-based facility provides the CTD/eCTD Dossiers and stability data required for international registration.

  • Cerebral Edema & Oncology: While 0.5 mg is a low dose, it is part of a broader portfolio that includes high-strength injectables used to reduce inflammation associated with brain tumors.

 

What is Dapsone 50mg used for?

In the pharmaceutical industry, Dapsone 50 mg is a powerful sulfone derivative that functions as both a bacteriostatic antimicrobial and an anti-inflammatory agent. As a pharmacist and manufacturer, you likely recognize it as a core component of Multi-Drug Therapy (MDT) for leprosy, but its clinical utility has expanded significantly into dermatology.

Primary Clinical Uses

  • Leprosy (Hansen’s Disease): Used in combination with Rifampicin and Clofazimine to treat all forms of leprosy. The 50 mg dose is often used in pediatric regimens or as part of a titrated adult dose.

  • Dermatitis Herpetiformis (DH): This is the “gold standard” treatment for this chronic, intensely itchy, blistering skin condition associated with celiac disease. It provides rapid relief from itching and lesions.

  • Pneumocystis Jirovecii Pneumonia (PCP) Prophylaxis: Frequently prescribed for immunocompromised patients (such as those with HIV) who are allergic to or cannot tolerate Sulfamethoxazole/Trimethoprim (Septran/Bactrim).

  • Acne Vulgaris: While often used as a topical gel, oral Dapsone is sometimes used for severe, recalcitrant inflammatory acne.

  • Brown Recluse Spider Bites: Occasionally used off-label to limit the necrotic skin damage caused by these bites.

Mechanism of Action

Dapsone is a dual-action molecule:

Antimicrobial Action: It acts as a competitive inhibitor of dihydropteroate synthase, an enzyme involved in the synthesis of dihydrofolic acid in bacteria and protozoa. By blocking folate synthesis, it prevents the organism from producing the DNA and RNA needed to multiply.

Anti-inflammatory Action: It inhibits the migration of neutrophils to the site of inflammation and suppresses the production of reactive oxygen species (free radicals), which helps reduce tissue damage in autoimmune skin conditions.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Dapsone 50 mg is a specialized product requiring specific quality standards:

  • API Stability: Dapsone is relatively stable but can be sensitive to light. As a WHO-GMP manufacturer, we utilize opaque PVC/PVDC or Alu-Alu blister packaging to ensure its 36-month shelf life, especially for export to Zone IVb (hot and humid) regions.

  • Content Uniformity: Because it is a potent molecule, our manufacturing process utilizes validated blending and granulation techniques to ensure absolute dose precision across every batch.

  • Global Health Tenders: Dapsone is a “World Health Organization Essential Medicine.” It is a high-demand item for government health tenders and NGOs focusing on leprosy and HIV/AIDS care in Africa and Southeast Asia.

  • Safety Monitoring: As a pharmacist, you know the risk of Hemolytic Anemia and Methemoglobinemia, particularly in patients with G6PD deficiency. We ensure our Product Information Leaflets (PIL) and dossiers clearly state the need for baseline blood tests.

 

What is Cyproheptadine 4 mg used for?

In the pharmaceutical industry, Cyproheptadine Hydrochloride 4 mg is a versatile first-generation antihistamine of the piperidine class. As a pharmacist, you likely recognize it not just for allergy relief, but for its unique ability to antagonize serotonin receptors, which differentiates it from most other antihistamines.

Primary Clinical Uses

  • Appetite Stimulation: This is one of its most common “off-label” uses in many international markets. It is prescribed for children and adults with failure to thrive, malnutrition, or anorexia to promote weight gain.

  • Allergic Reactions: Relieves symptoms of seasonal and perennial allergic rhinitis, hay fever, and allergic conjunctivitis.

  • Dermatological Conditions: Highly effective for urticaria (hives), angioedema, and pruritus (itching) associated with skin allergies.

  • Serotonin Syndrome: Utilized as a specific antidote in hospital settings to counteract the effects of “Serotonin Syndrome” caused by an overdose or interaction of serotonergic drugs (like SSRIs).

  • Vascular Headaches: Occasionally used for the prophylaxis (prevention) of migraines and cluster headaches.

Mechanism of Action

Cyproheptadine is a potent antagonist at two distinct receptor sites:

H1-Receptor Antagonism: It competes with free histamine for binding sites on effector cells, preventing the inflammatory response.

5-HT2 Receptor Antagonism: It blocks serotonin receptors in the hypothalamus. This is the mechanism behind its appetite-stimulating effect; by blocking these receptors, it inhibits the “satiety center,” leading to increased hunger.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Cyproheptadine 4 mg is a high-volume product with significant B2B demand:

  • Dose Uniformity: With a 4 mg active ingredient, our WHO-GMP manufacturing process focuses on validated blending and granulation to ensure that every tablet in a million-tablet batch meets the exact assay requirements.

  • Formulation Varieties: Beyond the 4 mg tablets, it is frequently manufactured as a 2 mg/5 ml syrup. This is a staple for pediatric weight gain and is a major export item for many Indian firms.

  • Stability for Export: Cyproheptadine is relatively robust, but we utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life, especially for export to Zone IVb (hot and humid) regions like Africa and Southeast Asia.

  • B2B Market Positioning: Because of its appetite-stimulating properties, it is often marketed alongside multivitamins or lysine in many emerging markets.

What is Sulphamethoxazole and Trimethoprim tablets used for?

In the pharmaceutical industry, the combination of Sulfamethoxazole and Trimethoprim (SMZ-TMP)—also known as Co-trimoxazole—is a classic example of synergistic antimicrobial therapy. As a pharmacist, I view this as a powerful “sequential blockade” tool, where the two components work together to inhibit bacterial folic acid synthesis far more effectively than either could alone.

Primary Clinical Uses

  • Urinary Tract Infections (UTIs): Often a first-line treatment for uncomplicated UTIs, pyelonephritis, and prostatitis caused by susceptible strains of E. coli or Klebsiella.

  • Respiratory Infections: Used for acute exacerbations of chronic bronchitis and certain types of pneumonia.

  • Pneumocystis Jirovecii Pneumonia (PJP): The “gold standard” for both the treatment and prophylaxis of PJP in immunocompromised patients (such as those with HIV/AIDS).

  • Gastrointestinal Infections: Effective against Shigellosis, Traveler’s Diarrhea, and Cholera.

  • MRSA Skin Infections: Increasingly utilized for community-acquired Methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections.

Mechanism of Action: The Sequential Blockade

SMZ-TMP is bactericidal because it inhibits two consecutive steps in the biosynthesis of nucleic acids and proteins essential to many bacteria:

Sulfamethoxazole: A sulfonamide that competitively inhibits the enzyme dihydropteroate synthase. It mimics PABA (para-aminobenzoic acid), preventing the bacteria from synthesizing dihydrofolic acid.

Trimethoprim: It binds to and reversibly inhibits the next enzyme in the chain, dihydrofolate reductase, preventing the reduction of dihydrofolic acid to tetrahydrofolic acid (the active form of folate).

By attacking two points in the same metabolic pathway, the combination significantly reduces the development of bacterial resistance and enhances the overall potency.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, SMZ-TMP (Standard 400 mg/80 mg or DS 800 mg/160 mg) is a high-volume essential:

  • Fixed-Dose Ratio (5:1): As a WHO-GMP manufacturer, we strictly maintain the 5:1 ratio of Sulfamethoxazole to Trimethoprim. This ratio is optimized to achieve a steady-state plasma concentration ratio of 20:1, which is the peak synergistic level in the blood.

  • Solubility & Dissolution: Sulfamethoxazole is poorly soluble in water. We utilize specific granulation and disintegration agents to ensure the tablet meets pharmacopeial dissolution standards (BP/USP/IP), ensuring maximum bioavailability.

  • Global Tender Staple: Because it is on the WHO Model List of Essential Medicines, it is a constant requirement for government health tenders and B2B distributors in Africa and Southeast Asia.

  • Packaging for Stability: We prioritize PVC/PVDC or Alu-Alu blister packaging to protect the formulation from moisture, ensuring a 36-month shelf life for export to Zone IVb climates.

 

What is Co-Trimoxazole Sulfamethoxazole Trimethoprim used for?

In the pharmaceutical industry, the combination of Sulfamethoxazole and Trimethoprim (SMZ-TMP)—clinically referred to as Co-trimoxazole—is a classic example of synergistic antimicrobial therapy. As a pharmacist, I characterize this as a “sequential blockade” antibiotic, which remains a staple in both community and hospital settings due to its broad-spectrum efficacy and excellent tissue penetration.

Primary Clinical Uses

  • Urinary Tract Infections (UTIs): A primary treatment for acute uncomplicated cystitis and pyelonephritis, particularly those caused by E. coli or Klebsiella species.

  • Pneumocystis Jirovecii Pneumonia (PJP): The “gold standard” for both the treatment and prophylaxis of PJP in immunocompromised patients (e.g., those with HIV/AIDS).

  • Respiratory Tract Infections: Used for acute exacerbations of chronic bronchitis and acute otitis media in children.

  • Gastrointestinal Infections: Indicated for Shigellosis and Traveler’s Diarrhea.

  • MRSA Management: Increasingly utilized as a cost-effective oral option for treating community-acquired Methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections.

Mechanism of Action: The Sequential Blockade

The synergy of this combination is achieved by inhibiting two consecutive steps in the bacterial synthesis of Tetrahydrofolic acid (essential for DNA production):

Sulfamethoxazole: Acts as a structural analog of PABA, competitively inhibiting the enzyme dihydropteroate synthase.

Trimethoprim: Reversibly inhibits the enzyme dihydrofolate reductase.

By targeting the same metabolic pathway at two different points, the combination becomes bactericidal, whereas each component used alone is typically only bacteriostatic.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, SMZ-TMP is a high-volume, essential medicine requiring specific technical rigor:

  • Fixed-Dose Ratio (1:5): Whether in standard (80mg/400mg) or Double Strength (160mg/800mg) formats, maintaining the 1:5 ratio is critical to achieving the 1:20 plasma concentration ratio required for peak synergy.

  • API Handling: As a WHO-GMP manufacturer, we manage the slightly acidic nature of Sulfamethoxazole and the basic nature of Trimethoprim during the granulation process to ensure final tablet stability and uniform dissolution.

  • Stability for Export: This is a core product for international B2B distributors and government health tenders. We utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life in Zone IVb (hot and humid) climates like Africa and Southeast Asia.

  • Regulatory Compliance: Our Mumbai-based facility provides complete CTD/eCTD Dossiers and stability data (BP/USP/IP) to support our partners in global registration.

 

Add to cart